Proto Labs, Inc. (0KRR.L)
| Previous close | 32.06 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 572 |
| Market cap | 9.047M |
| Beta (5Y monthly) | 1.36 |
| PE ratio (TTM) | 0.26 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Protolabs to Participate in Upcoming Industry and Investor Conferences
MINNEAPOLIS, May 16, 2024--Protolabs (NYSE: PRLB), provider of the fastest and most comprehensive digital manufacturing service in the world, today announced that the company will present at the following two upcoming conferences:
- Business Wire
Protolabs Reports Financial Results for the First Quarter of 2024
MINNEAPOLIS, May 03, 2024--Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the first quarter ended March 31, 2024.
- Business Wire
Paralympic Gold Medalist Creates Custom Prosthetics for Athletes through Protolabs' Digital Manufacturing Service
MINNEAPOLIS, May 01, 2024--Protolabs (NYSE: PRLB) highlights its critical work with BioDapt, a company that designs, manufactures, and distributes high-performance lower limb prosthetic equipment used for action sports and other activities with similar physical demands. This is just one of the many ways Protolabs positively impacts the world through its unique, hybrid digital manufacturing model that combines its own digital factories with a network of global manufacturing partners.
